Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight

Christine Mack, Julie Wilson, Jennifer Athanacio, James Reynolds, Kevin Laugero, Stacy Guss, Calvin Vu, Jonathan Roth, David Parkes

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

The ability of amylin to reduce acute food intake in rodents is well established. Longer-term administration in rats (up to 24 days) shows a concomitant reduction in body weight, suggesting energy intake plays a significant role in mediating amylin-induced weight loss. The current set of experiments further explores the long-term effects of amylin (4-11 wk) on food preference, energy expenditure, and body weight and composition. Furthermore, we describe the acute effect of amylin on locomotor activity and kaolin consumption to test for possible nonhomeostatic mechanisms that could affect food intake. Four-week subcutaneous amylin infusion of high-fat fed rats (3-300 μg·kg-1·day-1) dose dependently reduced food intake and body weight gain (ED50 for body weight gain = 16.5 μg·kg-1·day-1). The effect of amylin on body weight gain was durable for up to 11 wks and was associated with a specific loss of fat mass and increased metabolic rate. The body weight of rats withdrawn from amylin (100 μg·kg-1·day-1) after 4 wks of infusion returned to control levels 2 wks after treatment cessation, but did not rebound above control levels. When self-selecting calories from a low- or high-fat diet during 11 wks of infusion, amylin-treated rats (300 μg·kg-1·day-1) consistently chose a larger percentage of calories from the low-fat diet vs. controls. Amylin acutely had no effect on locomotor activity or kaolin consumption at doses that decreased food intake. These results demonstrate pharmacological actions of amylin in long-term body weight regulation in part through appetitive-related mechanisms and possibly via changes in food preference and energy expenditure.

Original languageEnglish (US)
JournalAmerican Journal of Physiology - Regulatory Integrative and Comparative Physiology
Volume293
Issue number5
DOIs
StatePublished - Nov 2007
Externally publishedYes

Fingerprint

Islet Amyloid Polypeptide
Appetite Regulation
Food Preferences
Peptide Hormones
Body Weight
Pharmacology
Eating
Weight Gain
Kaolin
Fats
Locomotion
Energy Metabolism
Subcutaneous Infusions
Fat-Restricted Diet
Withholding Treatment
Aptitude
High Fat Diet
Body Composition
Energy Intake
Weight Loss

Keywords

  • Body composition
  • Kaolin consumption
  • Locomotor activity
  • Meal size
  • Pramlintide

ASJC Scopus subject areas

  • Physiology

Cite this

Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. / Mack, Christine; Wilson, Julie; Athanacio, Jennifer; Reynolds, James; Laugero, Kevin; Guss, Stacy; Vu, Calvin; Roth, Jonathan; Parkes, David.

In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology, Vol. 293, No. 5, 11.2007.

Research output: Contribution to journalArticle

Mack, Christine ; Wilson, Julie ; Athanacio, Jennifer ; Reynolds, James ; Laugero, Kevin ; Guss, Stacy ; Vu, Calvin ; Roth, Jonathan ; Parkes, David. / Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight. In: American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 2007 ; Vol. 293, No. 5.
@article{65070d5f3c7d41849cade5d48dfaf29f,
title = "Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight",
abstract = "The ability of amylin to reduce acute food intake in rodents is well established. Longer-term administration in rats (up to 24 days) shows a concomitant reduction in body weight, suggesting energy intake plays a significant role in mediating amylin-induced weight loss. The current set of experiments further explores the long-term effects of amylin (4-11 wk) on food preference, energy expenditure, and body weight and composition. Furthermore, we describe the acute effect of amylin on locomotor activity and kaolin consumption to test for possible nonhomeostatic mechanisms that could affect food intake. Four-week subcutaneous amylin infusion of high-fat fed rats (3-300 μg·kg-1·day-1) dose dependently reduced food intake and body weight gain (ED50 for body weight gain = 16.5 μg·kg-1·day-1). The effect of amylin on body weight gain was durable for up to 11 wks and was associated with a specific loss of fat mass and increased metabolic rate. The body weight of rats withdrawn from amylin (100 μg·kg-1·day-1) after 4 wks of infusion returned to control levels 2 wks after treatment cessation, but did not rebound above control levels. When self-selecting calories from a low- or high-fat diet during 11 wks of infusion, amylin-treated rats (300 μg·kg-1·day-1) consistently chose a larger percentage of calories from the low-fat diet vs. controls. Amylin acutely had no effect on locomotor activity or kaolin consumption at doses that decreased food intake. These results demonstrate pharmacological actions of amylin in long-term body weight regulation in part through appetitive-related mechanisms and possibly via changes in food preference and energy expenditure.",
keywords = "Body composition, Kaolin consumption, Locomotor activity, Meal size, Pramlintide",
author = "Christine Mack and Julie Wilson and Jennifer Athanacio and James Reynolds and Kevin Laugero and Stacy Guss and Calvin Vu and Jonathan Roth and David Parkes",
year = "2007",
month = "11",
doi = "10.1152/ajpregu.00297.2007",
language = "English (US)",
volume = "293",
journal = "American Journal of Physiology - Renal Fluid and Electrolyte Physiology",
issn = "1931-857X",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Pharmacological actions of the peptide hormone amylin in the long-term regulation of food intake, food preference, and body weight

AU - Mack, Christine

AU - Wilson, Julie

AU - Athanacio, Jennifer

AU - Reynolds, James

AU - Laugero, Kevin

AU - Guss, Stacy

AU - Vu, Calvin

AU - Roth, Jonathan

AU - Parkes, David

PY - 2007/11

Y1 - 2007/11

N2 - The ability of amylin to reduce acute food intake in rodents is well established. Longer-term administration in rats (up to 24 days) shows a concomitant reduction in body weight, suggesting energy intake plays a significant role in mediating amylin-induced weight loss. The current set of experiments further explores the long-term effects of amylin (4-11 wk) on food preference, energy expenditure, and body weight and composition. Furthermore, we describe the acute effect of amylin on locomotor activity and kaolin consumption to test for possible nonhomeostatic mechanisms that could affect food intake. Four-week subcutaneous amylin infusion of high-fat fed rats (3-300 μg·kg-1·day-1) dose dependently reduced food intake and body weight gain (ED50 for body weight gain = 16.5 μg·kg-1·day-1). The effect of amylin on body weight gain was durable for up to 11 wks and was associated with a specific loss of fat mass and increased metabolic rate. The body weight of rats withdrawn from amylin (100 μg·kg-1·day-1) after 4 wks of infusion returned to control levels 2 wks after treatment cessation, but did not rebound above control levels. When self-selecting calories from a low- or high-fat diet during 11 wks of infusion, amylin-treated rats (300 μg·kg-1·day-1) consistently chose a larger percentage of calories from the low-fat diet vs. controls. Amylin acutely had no effect on locomotor activity or kaolin consumption at doses that decreased food intake. These results demonstrate pharmacological actions of amylin in long-term body weight regulation in part through appetitive-related mechanisms and possibly via changes in food preference and energy expenditure.

AB - The ability of amylin to reduce acute food intake in rodents is well established. Longer-term administration in rats (up to 24 days) shows a concomitant reduction in body weight, suggesting energy intake plays a significant role in mediating amylin-induced weight loss. The current set of experiments further explores the long-term effects of amylin (4-11 wk) on food preference, energy expenditure, and body weight and composition. Furthermore, we describe the acute effect of amylin on locomotor activity and kaolin consumption to test for possible nonhomeostatic mechanisms that could affect food intake. Four-week subcutaneous amylin infusion of high-fat fed rats (3-300 μg·kg-1·day-1) dose dependently reduced food intake and body weight gain (ED50 for body weight gain = 16.5 μg·kg-1·day-1). The effect of amylin on body weight gain was durable for up to 11 wks and was associated with a specific loss of fat mass and increased metabolic rate. The body weight of rats withdrawn from amylin (100 μg·kg-1·day-1) after 4 wks of infusion returned to control levels 2 wks after treatment cessation, but did not rebound above control levels. When self-selecting calories from a low- or high-fat diet during 11 wks of infusion, amylin-treated rats (300 μg·kg-1·day-1) consistently chose a larger percentage of calories from the low-fat diet vs. controls. Amylin acutely had no effect on locomotor activity or kaolin consumption at doses that decreased food intake. These results demonstrate pharmacological actions of amylin in long-term body weight regulation in part through appetitive-related mechanisms and possibly via changes in food preference and energy expenditure.

KW - Body composition

KW - Kaolin consumption

KW - Locomotor activity

KW - Meal size

KW - Pramlintide

UR - http://www.scopus.com/inward/record.url?scp=36049009296&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=36049009296&partnerID=8YFLogxK

U2 - 10.1152/ajpregu.00297.2007

DO - 10.1152/ajpregu.00297.2007

M3 - Article

C2 - 17855496

AN - SCOPUS:36049009296

VL - 293

JO - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

JF - American Journal of Physiology - Renal Fluid and Electrolyte Physiology

SN - 1931-857X

IS - 5

ER -